Spots Global Cancer Trial Database for IDH1 and OCT4 in High Grade Astrocytoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: IDH1 and OCT4 in High Grade Astrocytoma
Official Title: IDH1 and OCT4 Markers as a Prognostic Factor in Clinical Outcome of High Grade Astrocytic Glioma
Study ID: NCT06214689
Conditions
Interventions
Study Description
Brief Summary: observation of IDH1 and OCT4 markers level and high grade astrocytoma patients prognosis after excision.
Detailed Description: explore the relationship between prognosis and IDH1 and OCT4 biomarkers after high grade astrocytoma excision , according to progression free survival and overall survival , in prospective and retrospective samples.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
